Robinul and Haemoglobin decreased - a phase IV clinical study of FDA data

Summary:

Haemoglobin decreased is reported as a side effect among people who take Robinul (glycopyrrolate), especially for people who are male, 60+ old, also take Zofran, and have Metastases to bone.

The phase IV clinical study analyzes which people have Haemoglobin decreased when taking Robinul. It is created by eHealthMe based on reports of 1,584 people who have side effects when taking Robinul from the FDA, and is updated regularly.

What is Robinul?

Robinul has active ingredients of glycopyrrolate. It is often used in hyperhidrosis. eHealthMe is studying from 1,663 Robinul users. Check the latest studies of Robinul.

What is Haemoglobin decreased?

Haemoglobin decreased is found to be associated with 2,406 drugs and 3,132 conditions by eHealthMe. Check the latest studies of Haemoglobin decreased.

On Jul, 26, 2026

1,584 people reported to have side effects when taking Robinul.
Among them, 34 people (2.15%) have Haemoglobin decreased.

Could Robinul cause Haemoglobin decreased?

Among these 34 people:

What is the gender of people who have Haemoglobin decreased when taking Robinul? *

female: 38.24 %
male: 61.76 %

What is the age of people who have Haemoglobin decreased when taking Robinul? *

What are other drugs people take besides Robinul? *

What are other side effects people have besides Haemoglobin decreased? *

Fatigue (feeling of tiredness): 22 people, 64.71%
Oedema Peripheral (superficial swelling): 22 people, 64.71%
Dyspnea (difficult or laboured breathing): 22 people, 64.71%
Confusional State: 20 people, 58.82%
Hypotension (abnormally low blood pressure): 19 people, 55.88%
Weight Decreased: 18 people, 52.94%
Nausea (feeling of having an urge to vomit): 17 people, 50.00%
Headache (pain in head): 16 people, 47.06%
Neuropathy Peripheral (surface nerve damage): 16 people, 47.06%
Blood Urea Increased: 16 people, 47.06%

What are the existing conditions these people have? *

Prostate Cancer: 12 people, 35.29%
Metastases To Bone (cancer spreads to bone): 12 people, 35.29%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 6 people, 17.65%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 4 people, 11.76%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 5.88%
Secretion Discharge: 2 people, 5.88%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 5.88%
Adenocarcinoma (malignant tumour formed from glandular structures in epithelial tissue): 2 people, 5.88%
Squamous Cell Carcinoma (a cancer of a kind of epithelial cell): 1 person, 2.94%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 2.94%

* Approximation only. Some reports may have incomplete information.

Do you take Robinul and have Haemoglobin decreased?

- Check whether Haemoglobin decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Robinul:

Robinul (1,663 reports)

Browse all side effects of Robinul:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Haemoglobin decreased:

Haemoglobin decreased (2,406 drugs)

Browse all the conditions that are associated with Haemoglobin decreased:

Haemoglobin decreased (3,132 conditions)

Related publications that referenced our studies

D'souza S, Gowler V, "Glycopyrrolate‐induced respiratory arrest: an unusual side effect", Acta Anaesthesiologica Scandinavica, 2015 Mar .
D'souza S, Gowler V, "Glycopyrrolate‐induced respiratory arrest: an unusual side effect", Acta Anaesthesiologica Scandinavica, 2015 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on glycopyrrolate (the active ingredients of Robinul) and Robinul (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.